VOLAGIDEMAB

UNII:	77JYS6UZ0M
Formula:
Preferred Substance Name:	VOLAGIDEMAB
GSRS Full Record:	77JYS6UZ0M i

1233956-13-2
AMG-477
IMMUNOGLOBULIN G2, ANTI-(HUMAN GLUCAGON RECEPTOR) (HUMAN MONOCLONAL REMD 477 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REMD 477 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS GCGR (GLUCAGON RECEPTOR)), HOMO SAPIENS MONOCLONAL ANTIBODYGAMMA2 HEAVY CHAIN HOMO SAPIENS (1-454) (VH (HOMO SAPIENS IGHV3-33*01 (95.9%)-(IGHD)-IGHJ1*01(90.9%)) (8.8.21) (1-128)-HOMO SAPIENS IGHG2*01 (CH1 (129-226), HINGE (227-238), CH2 (239-347), CH3 (348-452), CHS (453-454)) (129-454)), (142-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-17*01 (96.8%)-IGKJ4*01 (100.0%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (230-230'':231-231'':234-234'':237-237'')-TETRAKISDISULFIDE
REMD-477
VOLAGIDEMAB [INN]
VOLAGIDEMAB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VOLAGIDEMAB

Synonyms and Mappings

Resources